EWMA 2023 – European Wound Management Association Congress
MESI is attending EWMA 2023 – European Wound Management Association Congress, from 3rd to 5th May 2023 in Milan, Italy. Visit us at booth 161 and discover our digital arterial assessment in woundcare. This includes 1-minute ABI and TBI to help distinguish between venous and arterial wounds, determine appropriate compression therapy, and discover PAD in high-risk patients, including diabetics.
How can MESI mTABLET help woundcare nurses at everyday work?
Woundcare nurses often make home visits and determine the level of compression for chronic wounds, e.g. due to lymphoedema or the diabetic foot. The MESI mTABLET can enhance their work in many ways. Nurse Jane Hampton explains:
ABI is an important indicator for:
Prevention, diagnosis and timely treatment of Peripheral Arterial Disease (PAD).
Appropriate assessment of venous disease or ulceration and further decision-making.
Compression therapy. ABI helps to decide on the use and level of compression therapy and the monitoring thereof.
Wound healing therapy. ABI helps to determine the presence or absence of PAD, and predict the healability of lower-leg wounds.
Make the MESI mTABLET ABI part of every lower-extremity examination. You can also add more tools and create a custom diagnostic system!
Custom protocols to guide you through the exams of patients with the same condition, saving time and assuring everyone the same level of care.
All these solutions require a single MESI mTABLET device and fit into one handy carry-on bag.
Whatever MESI tool you use, instantly share the diagnostic results with your GP or specialist. They can view the measurement to the same detail as on the MESI mTABLET even if they do not have the tablet themselves.